The collaboration will enable both the companies to provide specialized preclinical and early clinical development services in the neuroscience domain to their combined customer base.
JSW Lifesciences CEO Manfred Windisch said partnering with TCGLS gives them the opportunity to take advantage of ‘India benefit’ and work closely for mutual growth.
"We are confident that this strategic tie-up will be highly beneficial to both," Windisch said.